Common use of Termination if SGI Challenges Genmab Patents Clause in Contracts

Termination if SGI Challenges Genmab Patents. Genmab may terminate this Agreement for cause at any time after thirty (30) days written notice to SGI of its intent to so terminate if SGI, its Affiliates or Sublicensees, challenges the validity, enforceability, patentability or scope of a claim of any Genmab Patent. Any such termination shall not become effective if SGI has withdrawn such action before the end of the above notice period, provided such withdrawal effectively terminates that action and has not materially adversely affected any of Genmab’s rights under the Agreement.

Termination if SGI Challenges Genmab Patents. Genmab may terminate this Agreement for cause at any time after thirty (30) days [ * ] written notice to SGI of its intent to so terminate if SGI, its Affiliates or Sublicensees, challenges the validity, enforceability, patentability or scope of a claim of any Genmab Patent. Any such termination shall not become effective if SGI has withdrawn such action before the end of the above notice period[ * ], provided such withdrawal effectively terminates that action and has not materially adversely affected any of Genmab’s rights under the Agreement[ * ].

Termination if SGI Challenges Genmab Patents. Genmab may terminate this Agreement for cause at any time after thirty (30) days [ * ] written notice to SGI of its intent to so terminate if SGI, its Affiliates or Sublicensees, challenges the validity, enforceability, patentability or scope of a claim of any Genmab Patent. Any such termination shall not become effective if SGI has withdrawn such action before the end of the above notice period[ * ], provided such withdrawal effectively terminates that action and has not materially adversely affected any of Genmab’s rights under the Agreement.[ * ]. 17.6